{"schema_version":"secwatch.filing_event.v1","accession":"0000818479-25-000167","form_type":"8-K","ticker":"XRAY","cik":"0000818479","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2025-09-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.443546+00:00","generated_at":"2026-05-17T07:48:43.824523+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Dentsply Sirona Retains Wellspect Healthcare After Strategic Review, Ends Sale Process","bullets":["Strategic review of Wellspect begun Feb 2025 completed Sep 8, 2025; company decided to retain the business.","Wellspect is a leader in continence care with LoFric and Navina brands; mid-single digit organic sales growth in 2024.","CEO Dan Scavilla cited strong cash flow, untapped market potential, and a $2B addressable market for the decision.","Company conducted broad outreach and considered a sale but determined retention creates more stockholder value."],"urls":{"canonical":"https://secwatch.observer/filing/0000818479-25-000167","json":"https://secwatch.observer/filing/0000818479-25-000167.json","markdown":"https://secwatch.observer/filing/0000818479-25-000167.md","text":"https://secwatch.observer/filing/0000818479-25-000167.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818479/000081847925000167/0000818479-25-000167-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818479/000081847925000167/xray-20250908.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:48:43.824523+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}